Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,Inverse variance weighted,10,0.93 [0.9-0.96],1.21526677420163e-05,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS,Inverse variance weighted,10,1.08 [1.04-1.13],2.96422342285271e-05,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROPATHIES,Inverse variance weighted,10,1.05 [1.02-1.08],0.000385368408727833,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,J10_RESPDISOTH,Inverse variance weighted,3,0.83 [0.74-0.93],0.00130547659869201,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,J10_PNEUMONAS,Inverse variance weighted,3,0.86 [0.78-0.94],0.00190315738852985,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,Inverse variance weighted,10,0.9 [0.84-0.96],0.00246526458631118,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,Inverse variance weighted,10,0.64 [0.48-0.86],0.00288864533276645,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter V Mental and behavioural disorders,F5_DEPRESSION_DYSTHYMIA,Inverse variance weighted,10,0.94 [0.89-0.98],0.00576800235738534,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter V Mental and behavioural disorders,KRA_PSY_ANXIETY_EXMORE,Inverse variance weighted,10,0.94 [0.89-0.98],0.00634834874688303,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_STR_SAH,Inverse variance weighted,3,0.83 [0.73-0.95],0.00762953173962462,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter V Mental and behavioural disorders,F5_DEPRESSIO,Inverse variance weighted,10,0.93 [0.88-0.98],0.00894682848365538,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_MACULOPATHY_EXMORE,Inverse variance weighted,10,1.24 [1.05-1.47],0.0112230498672224,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,Inverse variance weighted,10,1.09 [1.02-1.17],0.0118770565740164,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,AB1_CANDIDIASIS,Inverse variance weighted,10,0.84 [0.73-0.97],0.0140128564533942,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,Inverse variance weighted,10,1.22 [1.04-1.44],0.0141615491684806,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,10,0.92 [0.87-0.99],0.0168259217940407,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,10,0.96 [0.93-1],0.0276187576052985,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOKALAEMIA,Inverse variance weighted,10,0.85 [0.74-0.99],0.0317025166674429,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_OTH,Inverse variance weighted,10,1.07 [1-1.13],0.0354111245591965,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,10,1.05 [1-1.1],0.0500909024789833,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,Inverse variance weighted,10,1.14 [1-1.3],0.0525694245474021,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,10,1.1 [1-1.2],0.0543520272083923,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter XV Pregnancy, childbirth and the puerperium",O15_COMPLIC_LAB_DELIV,Inverse variance weighted,10,1.04 [1-1.09],0.0597038926530786,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,AB1_INFECT_PARASIT,Inverse variance weighted,3,0.94 [0.88-1],0.0638603539212577,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Inverse variance weighted,10,1.08 [0.99-1.18],0.0769717350747704,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Inverse variance weighted,10,0.93 [0.85-1.01],0.0783110383999176,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_SEQULAE,Inverse variance weighted,10,0.92 [0.83-1.01],0.0785710938557762,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter V Mental and behavioural disorders,SMOKING_DEPEND,Inverse variance weighted,10,0.86 [0.72-1.02],0.0835654868488477,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_MI_STRICT,Inverse variance weighted,10,0.95 [0.89-1.01],0.0864762407401039,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,Inverse variance weighted,10,0.85 [0.71-1.03],0.098448921920235,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOPOROSIS,Inverse variance weighted,10,1.09 [0.98-1.2],0.0998638030792638,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_FIBROCHIRLIV,Inverse variance weighted,10,1.17 [0.97-1.42],0.104402024298305,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,10,1.23 [0.95-1.6],0.113079695667056,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,COPD_LATER,Inverse variance weighted,10,0.93 [0.86-1.02],0.116100024000567,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN,Inverse variance weighted,10,0.96 [0.9-1.01],0.121070477369502,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,AB1_MYCOSES,Inverse variance weighted,10,0.93 [0.85-1.02],0.134807571887119,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_IMPLICIT,Inverse variance weighted,3,0.93 [0.85-1.02],0.143605137586269,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2OPTH,Inverse variance weighted,10,1.15 [0.95-1.39],0.150955460206814,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUE,Inverse variance weighted,10,1.02 [0.99-1.06],0.163613773925908,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_RBBB,Inverse variance weighted,10,1.26 [0.91-1.74],0.166616609788024,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_STR,Inverse variance weighted,10,0.96 [0.91-1.02],0.172966100451928,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_OTHFUNC,Inverse variance weighted,10,0.95 [0.88-1.02],0.173369745646195,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,N14_CHRONEPHROPATH,Inverse variance weighted,10,1.19 [0.93-1.52],0.173854546738107,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOCHONDRO,Inverse variance weighted,10,1.04 [0.98-1.11],0.178036154078211,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_STR_EXH,Inverse variance weighted,3,0.9 [0.78-1.05],0.182909748708807,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,Inverse variance weighted,10,1.1 [0.95-1.26],0.202672411810851,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_NSTEMI,Inverse variance weighted,3,1.15 [0.93-1.44],0.203460379028953,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Inverse variance weighted,10,0.97 [0.91-1.02],0.209271516655115,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERANAEMIA,Inverse variance weighted,3,0.94 [0.85-1.04],0.210958667699806,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter V Mental and behavioural disorders,F5_DELIRIUM,Inverse variance weighted,10,0.87 [0.7-1.08],0.211240603692822,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_CONDITION,Inverse variance weighted,3,0.95 [0.88-1.03],0.211752628530377,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XII Diseases of the skin and subcutaneous tissue,L12_OTHERSKINSUBCUTIS,Inverse variance weighted,10,1.04 [0.98-1.1],0.215614185359788,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,ILD,Inverse variance weighted,10,0.92 [0.81-1.05],0.216149649531311,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_FUNGAL_IMPL,Inverse variance weighted,3,0.85 [0.66-1.1],0.217579816833203,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_CARDARR,Inverse variance weighted,10,0.87 [0.69-1.09],0.218725784602974,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,Inverse variance weighted,10,1.47 [0.79-2.74],0.22298831773758,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,COPD_EARLY,Inverse variance weighted,10,0.92 [0.8-1.05],0.22362023737033,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CHOROIDRETINA,Inverse variance weighted,10,1.03 [0.98-1.08],0.233546369365854,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_OTHDISSTOMDUOD,Inverse variance weighted,10,1.16 [0.9-1.5],0.244467930819005,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,Inverse variance weighted,10,1.1 [0.94-1.29],0.255859295676087,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_VARICVEOES,Inverse variance weighted,10,1.16 [0.9-1.5],0.258761019837873,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,J10_PLEURA,Inverse variance weighted,10,0.96 [0.9-1.03],0.266580207950167,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XII Diseases of the skin and subcutaneous tissue,L12_CELLULITIS,Inverse variance weighted,10,0.94 [0.85-1.04],0.266739614026339,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,AB1_BACT_BIR_OTHER_INF_AGENTS,Inverse variance weighted,10,0.87 [0.68-1.12],0.271556480143466,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRLOW,Inverse variance weighted,10,0.86 [0.66-1.12],0.272532182083028,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_INTESTOTH,Inverse variance weighted,10,0.98 [0.95-1.02],0.288127782031349,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Inverse variance weighted,10,1.07 [0.94-1.22],0.288447357725506,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_CORATHER,Inverse variance weighted,10,0.97 [0.93-1.02],0.294797664424666,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,Inverse variance weighted,10,1.13 [0.9-1.42],0.297809805647613,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_HYPTENSPOR,Inverse variance weighted,3,0.81 [0.54-1.21],0.297851923942716,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_CHD,Inverse variance weighted,10,0.97 [0.91-1.03],0.312350790525947,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SJOGREN,Inverse variance weighted,10,1.12 [0.89-1.4],0.336459829302144,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Inverse variance weighted,10,1.04 [0.95-1.14],0.355353361251425,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,Inverse variance weighted,10,1.05 [0.95-1.17],0.364561095255296,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_GIDISEASES,Inverse variance weighted,3,0.98 [0.93-1.03],0.364663985099465,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SLE,Inverse variance weighted,3,1.55 [0.59-4.05],0.369587572085425,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,J10_LOWERINF,Inverse variance weighted,10,0.97 [0.92-1.03],0.373825575965888,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_IHD,Inverse variance weighted,10,0.98 [0.94-1.02],0.374614876251314,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Inverse variance weighted,10,1.05 [0.94-1.16],0.375767641196573,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,Inverse variance weighted,10,1.03 [0.97-1.1],0.38156951270269,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,Inverse variance weighted,10,0.98 [0.93-1.03],0.381948107563791,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,ASTHMA_NAS,Inverse variance weighted,10,0.97 [0.91-1.04],0.384326064853916,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,IPF,Inverse variance weighted,10,0.92 [0.77-1.11],0.391155954208187,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,Inverse variance weighted,3,1.12 [0.86-1.48],0.400053360568442,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_LBBB,Inverse variance weighted,10,0.92 [0.76-1.11],0.400091428098391,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN_NAS,Inverse variance weighted,3,0.89 [0.68-1.17],0.402292182209553,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter II Neoplasms,C3_NONHODGKIN_EXALLC,Inverse variance weighted,10,1.14 [0.83-1.57],0.404157570925865,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_PERITONITIS,Inverse variance weighted,10,0.92 [0.76-1.12],0.406024600200906,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Inverse variance weighted,10,1.07 [0.91-1.26],0.412496440177161,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_OESSTODUO,Inverse variance weighted,10,1.02 [0.97-1.08],0.417659951064391,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,AB1_INTESTINAL_INFECTIONS,Inverse variance weighted,10,0.98 [0.93-1.03],0.418008210645853,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_CONSTIPATION,Inverse variance weighted,10,0.98 [0.94-1.03],0.423593757540777,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_BCKGRND_RETINA,Inverse variance weighted,3,0.89 [0.66-1.19],0.430603486710211,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_MUSCULOSKELETAL,Inverse variance weighted,3,0.98 [0.93-1.03],0.436658766319182,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_HYPTENS,Inverse variance weighted,10,1.02 [0.98-1.06],0.440450166495815,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,COLITNONINFNAS,Inverse variance weighted,3,1.06 [0.91-1.22],0.446652301195906,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHRITISNAS,Inverse variance weighted,3,0.96 [0.88-1.06],0.455686807018342,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_SARCOIDOSIS,Inverse variance weighted,10,1.05 [0.92-1.2],0.457893749191445,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Inverse variance weighted,10,0.98 [0.93-1.04],0.462950554757103,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_PAD,Inverse variance weighted,3,1.07 [0.89-1.28],0.465083792312941,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,Inverse variance weighted,10,0.95 [0.83-1.09],0.46537070575396,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_ANGINA,Inverse variance weighted,10,0.98 [0.93-1.04],0.47251108253205,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,CHRONNAS,Inverse variance weighted,10,1.09 [0.86-1.38],0.479086187521543,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,Inverse variance weighted,10,1.02 [0.97-1.06],0.507981622987016,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_OTHINT,Inverse variance weighted,10,1.05 [0.91-1.22],0.511164694317091,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_EXPLICIT,Inverse variance weighted,3,0.96 [0.85-1.09],0.512434347335725,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,J10_ASTHMA_EXMORE,Inverse variance weighted,10,0.99 [0.94-1.03],0.517955443131757,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_ALCOLIV,Inverse variance weighted,10,0.95 [0.81-1.11],0.518528184791839,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,Inverse variance weighted,10,1.09 [0.83-1.44],0.533378429908554,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,N14_URINOTH,Inverse variance weighted,10,0.98 [0.93-1.04],0.536457190140438,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHY,Inverse variance weighted,10,0.99 [0.95-1.03],0.544100627676528,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,J10_PNEUMONISOLLIQ,Inverse variance weighted,10,0.95 [0.8-1.13],0.544332849077815,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Inverse variance weighted,10,1.02 [0.95-1.1],0.545722336464952,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,Inverse variance weighted,3,0.9 [0.65-1.26],0.552826814166305,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter VI Diseases of the nervous system,G6_EPIPAROX,Inverse variance weighted,10,1.01 [0.98-1.04],0.555744474710297,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_VIRAL_IMPL,Inverse variance weighted,3,1.06 [0.87-1.3],0.557799920825252,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,AB1_STREPTSTAPHYCOCC_INOTHER,Inverse variance weighted,10,0.81 [0.4-1.63],0.557934778092285,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,Inverse variance weighted,10,0.98 [0.91-1.06],0.563668420783452,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_OTHILLHEART,Inverse variance weighted,10,0.93 [0.74-1.18],0.564757380345008,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Inverse variance weighted,10,1.03 [0.94-1.13],0.573983197060069,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,Inverse variance weighted,10,0.89 [0.6-1.33],0.575331849233248,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,10,0.98 [0.91-1.05],0.581008636510802,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,Inverse variance weighted,10,1.08 [0.82-1.43],0.582595284909452,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OTHCONN,Inverse variance weighted,3,1.08 [0.83-1.39],0.582798245900326,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,J10_INTERSTITIUM,Inverse variance weighted,3,0.94 [0.75-1.17],0.583287986929861,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter VI Diseases of the nervous system,FALLS,Inverse variance weighted,10,1.01 [0.98-1.04],0.585525837648591,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XII Diseases of the skin and subcutaneous tissue,L12_ULCERLOWLIMB,Inverse variance weighted,10,1.04 [0.9-1.21],0.597147813900357,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,Inverse variance weighted,10,0.93 [0.72-1.21],0.602394730333063,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XII Diseases of the skin and subcutaneous tissue,L12_SKIN_SUBCUTAN,Inverse variance weighted,3,1.02 [0.94-1.11],0.60334900778317,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,JOINTPAIN,Inverse variance weighted,10,1.01 [0.96-1.07],0.613391869246034,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,Inverse variance weighted,3,0.94 [0.75-1.19],0.613864235452161,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CATARACTOTHER,Inverse variance weighted,10,0.98 [0.92-1.05],0.61737282407924,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,J10_EMPHYSEMA,Inverse variance weighted,10,0.95 [0.79-1.15],0.621223452230606,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter VI Diseases of the nervous system,G6_HEMIPLE,Inverse variance weighted,10,1.05 [0.85-1.3],0.630135234092962,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_HEPFAIL,Inverse variance weighted,10,0.93 [0.69-1.26],0.632584319774099,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Inverse variance weighted,10,1.04 [0.88-1.23],0.633359285523494,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,PNEUMOBACTKNOWN,Inverse variance weighted,3,0.91 [0.62-1.34],0.640301767326395,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter VI Diseases of the nervous system,G6_CPETAL,Inverse variance weighted,10,1.04 [0.87-1.25],0.654554341249371,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_HYPTENSPUL,Inverse variance weighted,10,0.83 [0.36-1.89],0.658469246857663,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_UAP,Inverse variance weighted,10,0.98 [0.9-1.07],0.67274326826479,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter V Mental and behavioural disorders,KRA_PSY_MOOD_EXMORE,Inverse variance weighted,3,0.98 [0.9-1.07],0.673002106913832,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,3,1.02 [0.94-1.11],0.675925669894141,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_OTHARR,Inverse variance weighted,10,1.02 [0.93-1.11],0.68162311064774,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,N14_RENFAILNAS,Inverse variance weighted,10,1.03 [0.88-1.22],0.683656801181896,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_BLOOD_IMMUN,Inverse variance weighted,3,0.99 [0.92-1.06],0.684887309577539,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,10,1.05 [0.82-1.34],0.69418969118375,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,J10_ACUTELOWERNAS,Inverse variance weighted,10,0.98 [0.87-1.1],0.705571035858008,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACT_INOTHER,Inverse variance weighted,10,1.1 [0.66-1.83],0.714445881697445,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,Inverse variance weighted,10,0.87 [0.42-1.8],0.715045675631216,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_PULMOTHHD,Inverse variance weighted,3,0.95 [0.7-1.29],0.727985675102258,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Inverse variance weighted,10,1.01 [0.97-1.05],0.733862296025106,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,N14_GENITOURINARY,Inverse variance weighted,3,1.01 [0.96-1.06],0.738990575542679,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,J10_PLEUREFFUSION,Inverse variance weighted,10,1.02 [0.9-1.15],0.746156706680622,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERBLOOD,Inverse variance weighted,10,0.97 [0.8-1.17],0.759438512217362,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter VI Diseases of the nervous system,G6_NERPLEX,Inverse variance weighted,10,1.01 [0.96-1.06],0.76124342438629,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,Inverse variance weighted,10,1.03 [0.86-1.22],0.761804859950711,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,Inverse variance weighted,10,1.03 [0.85-1.25],0.762393915859251,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_RHEUVALV,Inverse variance weighted,10,1.05 [0.76-1.44],0.767648635782966,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,J10_RESPIRATORY,Inverse variance weighted,3,0.99 [0.94-1.05],0.773107979458624,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Inverse variance weighted,10,1.02 [0.9-1.15],0.785226702899888,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter VI Diseases of the nervous system,G6_NEURO,Inverse variance weighted,3,1.01 [0.95-1.07],0.790246445362107,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUEOTH,Inverse variance weighted,10,1.01 [0.95-1.06],0.793638024937824,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Inverse variance weighted,10,1.03 [0.83-1.27],0.799358865809812,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_AF,Inverse variance weighted,10,0.99 [0.92-1.07],0.80739912426662,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_PAROXTAC,Inverse variance weighted,10,0.99 [0.9-1.08],0.808170262660764,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,N14_ACUTERENFAIL,Inverse variance weighted,10,1.01 [0.91-1.13],0.813716532535832,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,N14_KIDUROTH,Inverse variance weighted,10,1.02 [0.86-1.2],0.814843697372145,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,J10_LOWCHRON,Inverse variance weighted,10,1 [0.96-1.03],0.817777826863956,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Inverse variance weighted,10,1.01 [0.95-1.06],0.82704842222946,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,COPD_HOSPITAL_MAIN,Inverse variance weighted,3,0.99 [0.89-1.1],0.830914799802272,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_HYPOTE,Inverse variance weighted,10,0.99 [0.87-1.12],0.831249062201125,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUENAS,Inverse variance weighted,10,0.98 [0.79-1.21],0.835920672857028,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,N14_OBSTRUREFLUROPATH,Inverse variance weighted,10,1.02 [0.86-1.21],0.842315826592018,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_OTHPER,Inverse variance weighted,10,1.02 [0.83-1.25],0.846706085289594,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_DISLIVOTH,Inverse variance weighted,10,0.98 [0.81-1.19],0.851253115735952,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_ARTOTH,Inverse variance weighted,10,0.98 [0.84-1.16],0.85133334637649,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Inverse variance weighted,10,0.99 [0.94-1.05],0.857474687244932,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XII Diseases of the skin and subcutaneous tissue,L12_OTHERCONTACT,Inverse variance weighted,10,0.99 [0.84-1.16],0.862623116133898,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Inverse variance weighted,10,0.99 [0.93-1.06],0.864600470937078,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,Inverse variance weighted,10,1.01 [0.92-1.1],0.867452490109313,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,10,1.01 [0.9-1.13],0.868358647452187,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,10,1 [0.95-1.06],0.86882349817297,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter XV Pregnancy, childbirth and the puerperium",O15_DELIV_PERIN_LACER,Inverse variance weighted,10,1.01 [0.9-1.14],0.871525314650747,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,J10_EXTERLUNG,Inverse variance weighted,10,1.01 [0.87-1.18],0.895251027861772,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,Inverse variance weighted,10,0.99 [0.79-1.22],0.897729510208713,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,Inverse variance weighted,10,1.01 [0.9-1.13],0.90456396229199,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,Inverse variance weighted,10,0.99 [0.85-1.16],0.905357306776554,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,C_DIFFICILE_ENTEROCOLITIS,Inverse variance weighted,10,0.99 [0.86-1.15],0.911641327207995,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter XV Pregnancy, childbirth and the puerperium",O15_MATERN_CARE,Inverse variance weighted,10,1 [0.95-1.06],0.912027602980316,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter II Neoplasms,LUNG_CANCER_MESOT,Inverse variance weighted,3,0.99 [0.71-1.38],0.9470256315408,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,Inverse variance weighted,10,1 [0.95-1.06],0.947681983850402,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Inverse variance weighted,10,0.99 [0.66-1.47],0.954219758861033,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIAINCHRONICDISEASE,Inverse variance weighted,10,1.01 [0.66-1.54],0.963662153793042,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_OTHOTH,Inverse variance weighted,10,1 [0.75-1.34],0.978991238829794,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_BACT_IMPL,Inverse variance weighted,3,1 [0.88-1.14],0.980300700004435,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,10,1 [0.9-1.1],0.984234920550802,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter VI Diseases of the nervous system,G6_POLYOTHUNS,Inverse variance weighted,10,1 [0.89-1.12],0.984647995068913,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SPONDYLOSIS,Inverse variance weighted,10,1 [0.92-1.09],0.98492424456372,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOMETPOSTOP,Inverse variance weighted,10,1 [0.85-1.18],0.987074720209401,cis
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,6,0.6 [0.46-0.79],0.000280090606472183,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_RHEUVALV,Inverse variance weighted,6,3.42 [1.38-8.47],0.0078523258921162,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,6,0.82 [0.71-0.95],0.00799408745735484,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Inverse variance weighted,6,0.85 [0.75-0.96],0.00804781500298835,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Inverse variance weighted,6,0.76 [0.61-0.95],0.015080579228099,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter XV Pregnancy, childbirth and the puerperium",O15_COMPLIC_LAB_DELIV,Inverse variance weighted,6,1.15 [1.02-1.31],0.0258211524951794,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,6,0.77 [0.61-0.98],0.0341291716642009,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS,Inverse variance weighted,6,0.84 [0.72-0.99],0.0380401170187355,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,Inverse variance weighted,6,0.52 [0.28-0.98],0.0445194408125277,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN,Inverse variance weighted,6,0.83 [0.69-1],0.0500404569300271,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XII Diseases of the skin and subcutaneous tissue,L12_ULCERLOWLIMB,Inverse variance weighted,6,0.67 [0.45-1],0.0509194834665876,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROPATHIES,Inverse variance weighted,6,0.89 [0.8-1],0.0556654398863493,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Inverse variance weighted,6,1.13 [0.99-1.29],0.0704125888812837,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_OTHPER,Inverse variance weighted,6,0.54 [0.27-1.07],0.078309588458654,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACT_INOTHER,Inverse variance weighted,6,4.31 [0.82-22.72],0.0847326216582324,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,CHRONNAS,Inverse variance weighted,6,1.6 [0.94-2.73],0.0857692498755442,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter V Mental and behavioural disorders,F5_DEPRESSION_DYSTHYMIA,Inverse variance weighted,6,1.11 [0.97-1.27],0.11797301172812,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,Inverse variance weighted,6,1.08 [0.98-1.18],0.120259777739262,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Inverse variance weighted,6,1.2 [0.95-1.51],0.123080310886377,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_ARTOTH,Inverse variance weighted,6,1.42 [0.89-2.25],0.143560123497725,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,Inverse variance weighted,6,0.63 [0.33-1.18],0.148691007714744,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_PAROXTAC,Inverse variance weighted,6,0.81 [0.61-1.08],0.153860310323957,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,Inverse variance weighted,6,0.84 [0.65-1.07],0.161417582230294,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,J10_EXTERLUNG,Inverse variance weighted,6,0.77 [0.53-1.11],0.166259672635647,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XII Diseases of the skin and subcutaneous tissue,L12_OTHERSKINSUBCUTIS,Inverse variance weighted,6,0.87 [0.71-1.06],0.169620912103785,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,J10_PLEUREFFUSION,Inverse variance weighted,6,0.79 [0.55-1.13],0.193299781315481,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,Inverse variance weighted,6,0.46 [0.15-1.48],0.193596415695808,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,AB1_BACT_BIR_OTHER_INF_AGENTS,Inverse variance weighted,6,1.37 [0.85-2.19],0.195049680576612,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Inverse variance weighted,6,0.8 [0.57-1.12],0.195854813262549,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,Inverse variance weighted,6,1.16 [0.92-1.45],0.206211115014995,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Inverse variance weighted,6,0.59 [0.25-1.38],0.224072995557372,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XII Diseases of the skin and subcutaneous tissue,L12_CELLULITIS,Inverse variance weighted,6,0.8 [0.55-1.16],0.240354680242163,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,C_DIFFICILE_ENTEROCOLITIS,Inverse variance weighted,6,0.78 [0.5-1.19],0.24758178753712,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_RBBB,Inverse variance weighted,6,1.56 [0.72-3.42],0.261444073676291,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_MI_STRICT,Inverse variance weighted,6,1.15 [0.9-1.47],0.263147879701683,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter VI Diseases of the nervous system,G6_NERPLEX,Inverse variance weighted,6,0.9 [0.75-1.08],0.273522461117852,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_OTHILLHEART,Inverse variance weighted,6,1.41 [0.76-2.61],0.27510755466499,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,Inverse variance weighted,6,1.13 [0.9-1.41],0.286089756230526,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_VARICVEOES,Inverse variance weighted,6,1.48 [0.7-3.13],0.308010835482836,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CHOROIDRETINA,Inverse variance weighted,6,1.13 [0.89-1.43],0.308196676871757,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,N14_CHRONEPHROPATH,Inverse variance weighted,6,0.69 [0.33-1.42],0.308973491469582,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Inverse variance weighted,6,1.14 [0.88-1.48],0.309588271176811,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,Inverse variance weighted,6,0.59 [0.21-1.64],0.311249815248116,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SPONDYLOSIS,Inverse variance weighted,6,0.91 [0.75-1.1],0.315856742258614,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_OESSTODUO,Inverse variance weighted,6,0.95 [0.85-1.06],0.345270673768591,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_ALCOLIV,Inverse variance weighted,6,1.31 [0.74-2.33],0.350036536163188,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,J10_EMPHYSEMA,Inverse variance weighted,6,0.77 [0.44-1.35],0.360220519577536,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Inverse variance weighted,6,1.16 [0.84-1.62],0.365552367887786,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,AB1_CANDIDIASIS,Inverse variance weighted,6,1.26 [0.76-2.07],0.366261390186835,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter V Mental and behavioural disorders,F5_DEPRESSIO,Inverse variance weighted,6,1.08 [0.9-1.3],0.386284520728465,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHY,Inverse variance weighted,6,0.96 [0.87-1.06],0.391327388167353,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_CONSTIPATION,Inverse variance weighted,6,1.06 [0.92-1.21],0.411504923025528,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOKALAEMIA,Inverse variance weighted,6,1.19 [0.78-1.81],0.418082065392199,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_SEQULAE,Inverse variance weighted,6,0.91 [0.72-1.15],0.426277195858759,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,Inverse variance weighted,6,0.74 [0.34-1.57],0.430422714181751,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,J10_PLEURA,Inverse variance weighted,6,0.92 [0.76-1.13],0.434739749830581,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,COPD_EARLY,Inverse variance weighted,6,0.89 [0.67-1.19],0.445458362849614,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter V Mental and behavioural disorders,SMOKING_DEPEND,Inverse variance weighted,6,0.82 [0.49-1.37],0.445914865484996,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIAINCHRONICDISEASE,Inverse variance weighted,6,0.68 [0.25-1.84],0.44669937630237,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Inverse variance weighted,6,0.84 [0.53-1.32],0.447622348861566,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,Inverse variance weighted,6,0.79 [0.42-1.46],0.451519820293094,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter VI Diseases of the nervous system,G6_POLYOTHUNS,Inverse variance weighted,6,1.12 [0.81-1.56],0.478892569229616,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,AB1_STREPTSTAPHYCOCC_INOTHER,Inverse variance weighted,6,2.46 [0.2-29.78],0.480025183796324,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,Inverse variance weighted,6,0.84 [0.52-1.36],0.481610250989099,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,Inverse variance weighted,6,1.11 [0.82-1.51],0.488304697748364,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,ILD,Inverse variance weighted,6,1.19 [0.73-1.96],0.490017114346361,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,Inverse variance weighted,6,0.51 [0.07-3.51],0.491184748071452,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,J10_LOWCHRON,Inverse variance weighted,6,0.96 [0.85-1.08],0.501305732034345,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter V Mental and behavioural disorders,KRA_PSY_ANXIETY_EXMORE,Inverse variance weighted,6,0.95 [0.83-1.09],0.50165327107085,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_INTESTOTH,Inverse variance weighted,6,0.97 [0.87-1.07],0.502759860003047,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERBLOOD,Inverse variance weighted,6,0.78 [0.38-1.61],0.507027264355424,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_OTHFUNC,Inverse variance weighted,6,0.93 [0.75-1.15],0.50930569059644,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,Inverse variance weighted,6,0.93 [0.74-1.17],0.521416453037458,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_CORATHER,Inverse variance weighted,6,1.06 [0.88-1.28],0.522140746634878,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Inverse variance weighted,6,0.94 [0.76-1.15],0.531368317142207,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_SARCOIDOSIS,Inverse variance weighted,6,1.2 [0.67-2.14],0.532547632386981,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Inverse variance weighted,6,0.9 [0.66-1.24],0.534900239866097,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter VI Diseases of the nervous system,G6_HEMIPLE,Inverse variance weighted,6,1.32 [0.54-3.21],0.539009083881874,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_MACULOPATHY_EXMORE,Inverse variance weighted,6,1.19 [0.67-2.11],0.543791838980862,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,J10_PNEUMONISOLLIQ,Inverse variance weighted,6,0.86 [0.52-1.41],0.54571357516667,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter VI Diseases of the nervous system,G6_CPETAL,Inverse variance weighted,6,1.13 [0.75-1.7],0.548052503069553,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,J10_LOWERINF,Inverse variance weighted,6,0.92 [0.71-1.21],0.559302391725246,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRLOW,Inverse variance weighted,6,1.37 [0.47-3.96],0.565147935793291,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,Inverse variance weighted,6,1.03 [0.92-1.17],0.57392212151605,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Inverse variance weighted,6,0.92 [0.67-1.25],0.579559764012309,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_HYPTENSPUL,Inverse variance weighted,6,0.64 [0.13-3.1],0.582061764386443,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,N14_ACUTERENFAIL,Inverse variance weighted,6,1.09 [0.79-1.52],0.58879120543838,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_HEPFAIL,Inverse variance weighted,6,0.81 [0.37-1.76],0.590538456585517,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Inverse variance weighted,6,0.96 [0.83-1.11],0.59456065130586,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SJOGREN,Inverse variance weighted,6,1.13 [0.7-1.84],0.607960420874578,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,COPD_LATER,Inverse variance weighted,6,0.94 [0.73-1.2],0.611747702468196,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_DISLIVOTH,Inverse variance weighted,6,1.09 [0.78-1.53],0.615769004745256,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2OPTH,Inverse variance weighted,6,1.1 [0.74-1.63],0.63102193477014,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,J10_ASTHMA_EXMORE,Inverse variance weighted,6,1.04 [0.88-1.23],0.634221548057979,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_CHD,Inverse variance weighted,6,1.06 [0.84-1.33],0.641300096697249,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,AB1_MYCOSES,Inverse variance weighted,6,1.07 [0.8-1.44],0.646496023516336,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,J10_ACUTELOWERNAS,Inverse variance weighted,6,0.92 [0.65-1.31],0.64848153200768,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_OTH,Inverse variance weighted,6,0.93 [0.69-1.26],0.652254472330108,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,Inverse variance weighted,6,0.89 [0.54-1.48],0.656510864369215,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_ANGINA,Inverse variance weighted,6,1.05 [0.85-1.29],0.660243159042356,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,Inverse variance weighted,6,1.08 [0.78-1.49],0.663411205489165,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_OTHOTH,Inverse variance weighted,6,1.21 [0.51-2.88],0.668276836825999,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,Inverse variance weighted,6,0.97 [0.85-1.11],0.669162335754223,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_OTHINT,Inverse variance weighted,6,1.1 [0.7-1.73],0.669476066917917,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,Inverse variance weighted,6,2.08 [0.07-60.3],0.669891319648415,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,Inverse variance weighted,6,1.19 [0.53-2.66],0.673977422704782,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUEOTH,Inverse variance weighted,6,0.97 [0.82-1.14],0.679924048833656,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOMETPOSTOP,Inverse variance weighted,6,1.13 [0.63-2.03],0.684401547669037,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,AB1_INTESTINAL_INFECTIONS,Inverse variance weighted,6,0.97 [0.84-1.12],0.690326144243641,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,JOINTPAIN,Inverse variance weighted,6,0.97 [0.83-1.14],0.709359382869953,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,6,1.03 [0.88-1.21],0.711181143028549,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,Inverse variance weighted,6,1.08 [0.72-1.6],0.712036805191981,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUENAS,Inverse variance weighted,6,1.13 [0.59-2.17],0.713941207680647,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,Inverse variance weighted,6,1.15 [0.54-2.44],0.715874692219607,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,ASTHMA_NAS,Inverse variance weighted,6,1.04 [0.85-1.27],0.721029810735316,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,Inverse variance weighted,6,1.04 [0.82-1.33],0.721857920236446,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Inverse variance weighted,6,0.8 [0.24-2.69],0.722084174789511,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,IPF,Inverse variance weighted,6,0.9 [0.49-1.66],0.728038068485103,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,Inverse variance weighted,6,0.92 [0.58-1.47],0.73023581366813,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_HYPTENS,Inverse variance weighted,6,1.03 [0.88-1.2],0.731716863703383,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,N14_OBSTRUREFLUROPATH,Inverse variance weighted,6,0.91 [0.5-1.63],0.739268217222291,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_PERITONITIS,Inverse variance weighted,6,1.1 [0.63-1.93],0.741083489479224,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOCHONDRO,Inverse variance weighted,6,1.03 [0.86-1.23],0.743668784413627,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CATARACTOTHER,Inverse variance weighted,6,1.04 [0.82-1.31],0.745061133447144,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter XV Pregnancy, childbirth and the puerperium",O15_DELIV_PERIN_LACER,Inverse variance weighted,6,1.06 [0.74-1.51],0.748661937279065,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,6,1.05 [0.77-1.42],0.750226499969457,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter VI Diseases of the nervous system,FALLS,Inverse variance weighted,6,1.01 [0.93-1.11],0.774460067320047,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter V Mental and behavioural disorders,F5_DELIRIUM,Inverse variance weighted,6,1.06 [0.69-1.65],0.781060997050863,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_HYPOTE,Inverse variance weighted,6,1.05 [0.73-1.52],0.783142813683751,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_FIBROCHIRLIV,Inverse variance weighted,6,0.89 [0.4-2.01],0.787154394757936,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_OTHARR,Inverse variance weighted,6,0.98 [0.84-1.14],0.791392642876701,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,6,0.99 [0.89-1.1],0.791444168425896,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Inverse variance weighted,6,0.97 [0.75-1.24],0.795688289220182,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_AF,Inverse variance weighted,6,1.02 [0.87-1.21],0.797483435153594,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Inverse variance weighted,6,0.98 [0.81-1.17],0.800815092134407,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,6,1.13 [0.44-2.9],0.801888211124352,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,N14_RENFAILNAS,Inverse variance weighted,6,1.06 [0.66-1.71],0.805012104659275,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Inverse variance weighted,6,1.05 [0.66-1.69],0.82566042790239,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_IHD,Inverse variance weighted,6,1.02 [0.85-1.22],0.828344695033903,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,6,1.09 [0.49-2.42],0.829558969791243,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_OTHDISSTOMDUOD,Inverse variance weighted,6,0.93 [0.49-1.76],0.831828373581695,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,N14_KIDUROTH,Inverse variance weighted,6,1.04 [0.7-1.57],0.832105718785243,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOPOROSIS,Inverse variance weighted,6,1.03 [0.77-1.37],0.845318219454388,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_CARDARR,Inverse variance weighted,6,1.05 [0.62-1.77],0.866327267585744,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XII Diseases of the skin and subcutaneous tissue,L12_OTHERCONTACT,Inverse variance weighted,6,1.07 [0.45-2.59],0.874698920162875,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,Inverse variance weighted,6,0.95 [0.47-1.9],0.877165212415161,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Inverse variance weighted,6,1.01 [0.88-1.17],0.879247212041839,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter II Neoplasms,C3_NONHODGKIN_EXALLC,Inverse variance weighted,6,1.05 [0.48-2.32],0.899379492408299,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUE,Inverse variance weighted,6,0.99 [0.88-1.12],0.90035169168756,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,Inverse variance weighted,6,0.97 [0.56-1.67],0.903323738783163,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter XV Pregnancy, childbirth and the puerperium",O15_MATERN_CARE,Inverse variance weighted,6,0.99 [0.84-1.17],0.904861694551115,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_STR,Inverse variance weighted,6,1.01 [0.86-1.19],0.918779315413096,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,Inverse variance weighted,6,0.97 [0.43-2.17],0.932945092973108,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_UAP,Inverse variance weighted,6,1.01 [0.8-1.26],0.94542860323236,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,N14_URINOTH,Inverse variance weighted,6,1 [0.89-1.13],0.954768131684109,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,6,1.01 [0.75-1.35],0.956927253620249,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,Inverse variance weighted,6,0.99 [0.78-1.27],0.960564336726365,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,Inverse variance weighted,6,1.02 [0.44-2.37],0.963982600470576,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter VI Diseases of the nervous system,G6_EPIPAROX,Inverse variance weighted,6,1 [0.9-1.11],0.964704088064054,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_LBBB,Inverse variance weighted,6,0.99 [0.52-1.88],0.982672423689241,trans
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,6,1 [0.83-1.21],0.998109738460261,trans
